Login / Signup

Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study.

Krishna M GokhaleNicola Jaime AdderleyAnuradhaa SubramanianWen Hwa LeeDiana HanJesse CokerTasanee BraithwaiteAlastair Keith DennistonPearse A KeaneKrishnarajah Nirantharakumar
Published in: The British journal of ophthalmology (2022)
We found no evidence that metformin was associated with risk of AMD in primary care patients requiring treatment for type 2 diabetes.
Keyphrases
  • age related macular degeneration
  • primary care
  • type diabetes
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • glycemic control
  • skeletal muscle